Financial Gravity Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Financial Gravity Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$104K	Hold	14	–	–	0.07%	304
2019 Q3	$1K	Hold	14	–	–	﹤0.01%	1054
2019 Q2	$1K	Sell	14 -640	-98%	-$47.1K	﹤0.01%	1075
2019 Q1	$51K	Buy	+654	New	+$49.5K	0.04%	312
2018 Q3	$33K	Buy	319 +303	+1,894%	+$45.7K	0.03%	414
2018 Q2	$2K	Buy	16 +5	+45%	+$558	﹤0.01%	1004
2018 Q1	$1K	Buy	+11	New	+$1.09K	﹤0.01%	1185

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Financial Gravity Asset Management's LGND Position: Q4 2019 in Review

Financial Gravity Asset Management held its Ligand Pharmaceuticals (LGND) position steady in Q4 2019 at 14 shares worth $104K. The position accounts for 0.07% of the portfolio, ranked #304.

Financial Gravity Asset Management first reported a position in LGND in Q1 2018 and has held it in 7 quarters since. 266 funds tracked by Wall St. Rank hold LGND as of Q4 2019.

Financial Gravity Asset Management held 14 shares of Ligand Pharmaceuticals worth $104K as of Q4 2019.
Financial Gravity Asset Management left its Ligand Pharmaceuticals share count unchanged in Q4 2019.
Ligand Pharmaceuticals made up 0.07% of Financial Gravity Asset Management's portfolio in Q4 2019, its #304 holding.
Financial Gravity Asset Management first reported a position in Ligand Pharmaceuticals in Q1 2018 and has held it in 7 quarters since.
266 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.